- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms Behind NAFLD: a System Genetics Perspective
Authors
Keywords
-
Journal
Current Atherosclerosis Reports
Volume 25, Issue 11, Pages 869-878
Publisher
Springer Science and Business Media LLC
Online
2023-10-09
DOI
10.1007/s11883-023-01158-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A clinical study of the correlation between metabolic-associated fatty liver disease and coronary plaque pattern
- (2023) Zhijiao Zhang et al. Scientific Reports
- The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
- (2023) Alexandra C. Finney et al. Frontiers in Cardiovascular Medicine
- Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
- (2022) P. Barton Duell et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis
- (2022) Marija Branković et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Polyene Phosphatidylcholine Ameliorates High Fat Diet-Induced Non-alcoholic Fatty Liver Disease via Remodeling Metabolism and Inflammation
- (2022) Yang Lu et al. Frontiers in Physiology
- The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
- (2022) Nicholas W.S. Chew et al. Frontiers in Genetics
- TM6SF2 rs58542926 is related to hepatic steatosis, fibrosis and serum lipids both in adults and children: A meta-analysis
- (2022) Xue-Ying Li et al. Frontiers in Endocrinology
- Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach
- (2022) Karolina Drożdż et al. Cardiovascular Diabetology
- Metabolomics and Lipidomics Screening Reveal Reprogrammed Signaling Pathways toward Cancer Development in Non-Alcoholic Steatohepatitis
- (2022) Eman A. Ahmed et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications
- (2022) Jie Fang et al. Frontiers in Cellular and Infection Microbiology
- Genetic regulation of liver lipids in a mouse model of insulin resistance and hepatic steatosis
- (2021) Frode Norheim et al. Molecular Systems Biology
- Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
- (2021) Anna Pia Delli Bovi et al. Frontiers in Medicine
- Mechanisms and disease consequences of nonalcoholic fatty liver disease
- (2021) Rohit Loomba et al. CELL
- Towards genetic prediction of non-alcoholic fatty liver disease trajectories: PNPLA3 and beyond
- (2020) Marcin Krawczyk et al. GASTROENTEROLOGY
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease
- (2020) Jian-Ting Wu et al. Lipids in Health and Disease
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
- (2020) Giovanni Targher et al. GUT
- NAFLD and cardiovascular diseases: a clinical review
- (2020) Philipp Kasper et al. Clinical Research in Cardiology
- An integrative systems genetic analysis of mammalian lipid metabolism
- (2019) Benjamin L. Parker et al. NATURE
- Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis
- (2019) Soumik BasuRay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice
- (2019) Daniel Lindén et al. Molecular Metabolism
- Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease
- (2019) Taliento et al. International Journal of Environmental Research and Public Health
- Fecal microbiota transplantation beyond Clostridioides difficile infections
- (2019) Koen Wortelboer et al. EBioMedicine
- Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2019) Bishuang Cai et al. Cell Metabolism
- Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis
- (2018) Giovanni Musso et al. GASTROENTEROLOGY
- The Genetic Architecture of Diet-induced Hepatic Fibrosis in Mice
- (2018) Simon T. Hui et al. HEPATOLOGY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
- (2018) Mario Masarone et al. Oxidative Medicine and Cellular Longevity
- Systems Analyses Reveal Physiological Roles and Genetic Regulators of Liver Lipid Species
- (2018) Pooja Jha et al. Cell Systems
- Role of vitamin E in nonalcoholic fatty liver disease
- (2018) Mayumi Nagashimada et al. IUBMB LIFE
- Phenome-wide association studies across large population cohorts support drug target validation
- (2018) Dorothée Diogo et al. Nature Communications
- The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation
- (2017) Soumik BasuRay et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis
- (2017) Nicole Ehrhardt et al. HUMAN MOLECULAR GENETICS
- Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
- (2017) P. Dongiovanni et al. JOURNAL OF INTERNAL MEDICINE
- Nonalcoholic fatty liver disease: Evolving paradigms
- (2017) Amedeo Lonardo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics
- (2017) Mingqian He et al. Cell and Bioscience
- Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center study
- (2017) Mireen Friedrich-Rust et al. PLoS One
- Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice
- (2016) Yanbo Fan et al. GASTROENTEROLOGY
- Inactivation ofTm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins
- (2016) Eriks Smagris et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Hybrid Mouse Diversity Panel: a resource for systems genetics analyses of metabolic and cardiovascular traits
- (2016) Aldons J. Lusis et al. JOURNAL OF LIPID RESEARCH
- Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
- (2016) Manoela Mota et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The role of the gut microbiota in NAFLD
- (2016) Christopher Leung et al. Nature Reviews Gastroenterology & Hepatology
- Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota?
- (2016) Lena K Brahe et al. Advances in Nutrition
- FXR Agonists as Therapeutic Agents for Non-alcoholic Fatty Liver Disease
- (2015) Rotonya M. Carr et al. Current Atherosclerosis Reports
- Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice
- (2015) Magdalena Mazagova et al. FASEB JOURNAL
- PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease
- (2015) Giovanni Musso et al. HEPATOLOGY
- S2k-Leitlinie nicht alkoholische Fettlebererkrankungen
- (2015) E. Roeb et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
- (2015) Chiara Saponaro et al. Nutrients
- Pnpla3I148Mknockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis
- (2014) Eriks Smagris et al. HEPATOLOGY
- Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
- (2014) Y.-L. Liu et al. JOURNAL OF HEPATOLOGY
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
- (2014) Julia Kozlitina et al. NATURE GENETICS
- TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content
- (2014) H. Mahdessian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function
- (2013) Piero Pingitore et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Genetic Control of Obesity and Gut Microbiota Composition in Response to High-Fat, High-Sucrose Diet in Mice
- (2013) Brian W. Parks et al. Cell Metabolism
- A 4-Polymorphism Risk Score Predicts Steatohepatitis in Children With Nonalcoholic Fatty Liver Disease
- (2013) Valerio Nobili et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease
- (2013) Salvatore Petta et al. PLoS One
- Adiponutrin Functions as a Nutritionally Regulated Lysophosphatidic Acid Acyltransferase
- (2012) Manju Kumari et al. Cell Metabolism
- Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population
- (2012) Maria Stepanova et al. Clinical Gastroenterology and Hepatology
- Antibiotics in early life alter the murine colonic microbiome and adiposity
- (2012) Ilseung Cho et al. NATURE
- Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans
- (2011) K. Sevastianova et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Genetic modifiers of non-alcoholic fatty liver disease progression
- (2011) Quentin M. Anstee et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
- (2011) Silvia Sookoian et al. HEPATOLOGY
- The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies
- (2011) Ahmad Al-Serri et al. JOURNAL OF HEPATOLOGY
- Genetic polymorphisms in non-alcoholic fatty liver disease in obese Egyptian children
- (2011) NehalM El-Koofy et al. Saudi Journal of Gastroenterology
- A position statement on NAFLD/NASH based on the EASL 2009 special conference
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome
- (2010) Mahesh K. Basantani et al. JOURNAL OF LIPID RESEARCH
- The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2010) Qing Liu et al. Lipids in Health and Disease
- Release of Inflammatory Mediators by Human Adipose Tissue Is Enhanced in Obesity and Primarily by the Nonfat Cells: A Review
- (2010) John N. Fain MEDIATORS OF INFLAMMATION
- Study of Cytochrome P450 2E1 and its allele Variants in Liver Injury of Nondiabetic, Nonalcoholic Steatohepatitis Obese Women
- (2009) NELSON M VARELA et al. BIOLOGICAL RESEARCH
- Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications
- (2009) Elisa Fabbrini et al. HEPATOLOGY
- A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis
- (2009) Shaoqing He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started